Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

42 Pages (Click to Jump) V  < 1 2 3 4 5 > »    
 
  
Reply to this topic

STI, STIRLING PRODUCTS LIMITED
bluebug
post Posted: Jan 11 2011, 01:21 PM
  Quote Post


Posts: 116
Thanks: 8


In Reply To: veeone's post @ Jan 30 2010, 08:24 AM

A very large turnover in STI today after a couple of interesting announcements.

This could be worth watching but there are as many shares outstanding as the US deficit.

Keep half an eye on both.

 
veeone
post Posted: Jan 30 2010, 08:24 AM
  Quote Post


Posts: 5,061
Thanks: 1115


Thursday, January 28, 2010
Australian healthcare company Stirling Products Limited (ASX:STI) will test its botanical extract ImmunoXel to treat flu.
The clinical trial will take place in the Ukraine. Classified as a dietary supplement, ImmunoXel is an immune system optimizing agent which helps the human body ‘naturally’ fight viruses.
Currently, two drugs - zanamivir and oseltamivir - are largely relied upon by doctors to be effective in combating the flu.
However, these two drugs are only able to shorten the duration of the flu by an average of about 1 or 2 days. These two drugs are associated with adverse side effects, but can also be prone to drug resistance.
ImmunoXel has already been shown to decrease the duration of the flu in clinical trial participants by 2 - 3 days.
The advantage of ImmunoXel is that it promotes optimized immune system function, and does not rely upon a drug effect against the virus itself.
ImmunoXel’s predecessor product, Dzherelo, is widely used in the Ukraine to lessen the effects and duration of the flu and also as a preventative.
The product is considered safe and effective both by its consumers and by the Ukraine government regulatory body.
In the upcoming trial, ImmunoXel effectiveness on the body’s immune system will be tested in people with seasonal flu (including swine flu, or 2009 H1N1 flu) both alone, and in tandem with conventional flu drugs.
If ImmunoXel’s effect on the immune system is synergistic with antiviral drugs in controlling the flu, such a combination of ImmunoXel as an immune system optimizer together with an antiviral drug may be a breakthrough for seasonal flu treatment.
The aim with ImmunoXel is to have a ‘natural’ process of successfully addressing the flu using the power of an optimized immune system alone, without the need of introducing drugs into the system.
Stirling will soon launch ImmunoXel in the USA, under the ‘i-Naturals’ branding. Marketing will focus on ImmunoXel’s demonstrated ability to assist and optimize the body’s naturally effective immune system. In addition to flu, published clinical trials have reported the efficacy of ImmunoXel in combating XDR-TB (extensively drug resistant tuberculosis), one of the world’s deadliest diseases.
Under the terms of the agreement governing the upcoming clinical trial in the Ukraine, Stirling will support laboratory costs, physician fees, and patient costs.
ImmunoXel will be supplied by the Company’s Licensor, Ekomed LLC, and antiviral drugs will be supplied by Stirling or its alliance partner Cipla Limited.
ImmunoXel has been the subject of over 12 clinical trials in cases of infectious diseases, and has been used by millions of people over the last 15 years.
Stirling recently raised $2m via a capital raising.
http://www.proactiveinvestors.com.au/compa...t-flu-4545.html



 
mullokintyre
post Posted: Jan 11 2010, 10:05 AM
  Quote Post


Posts: 3,343
Thanks: 1176


In Reply To: woddonnee's post @ Jan 5 2010, 09:06 PM

Good announcement re positive responses to aids drugs, but only on a small scale.
Bought in at 1.7 but looking at short term trade.
Mick



--------------------
sent from my Olivetti Typewriter.
 
woddonnee
post Posted: Jan 5 2010, 09:06 PM
  Quote Post


Posts: 192
Thanks: 22


In Reply To: binks's post @ Oct 22 2009, 02:45 PM

Perhaps the long suffering for holders has come to an end, been watching for a long time and bought at 1.5 today
cheers
Rod
Attached thumbnail(s)
Attached Image


 


 
binks
post Posted: Oct 22 2009, 02:45 PM
  Quote Post


Posts: 7
Thanks: 2


In Reply To: mailman32's post @ Apr 16 2009, 05:26 PM

I don't suppose todays ann has anything to do with their share purchase plan closing tomorrow

 
mailman32
post Posted: Apr 16 2009, 05:26 PM
  Quote Post


Posts: 63


In Reply To: dolor's post @ Apr 16 2009, 11:29 AM

Hey Dolor



Great announcement today, still in this stock from years ago.

Would love to hear from others with a better understanding on this NR, and where the company goes from here



Cheers !



 


dolor
post Posted: Apr 16 2009, 11:29 AM
  Quote Post


Posts: 143


In Reply To: dolor's post @ Apr 3 2009, 04:03 PM

Dramatic evidence for treatment of drug resistant TB and possibly HIV/Aids has sent this stock into a spin with great volume and price escalation this week. It seems no one on the east coast is interested in this one, but there may be plenty of opportunity for those keen on entry while STI is still a penny stock.

 
dolor
post Posted: Apr 3 2009, 04:03 PM
  Quote Post


Posts: 143


Stirling seems on the move with volumes up, price up 90%, and new product registration. Does this represent the start of a commercial future for this fledgling biotech? Anyone have the inside on this one?

 
billybongo
post Posted: Jan 13 2009, 11:29 AM
  Quote Post


Posts: 160


STi sterling products
prospecting for capital raising
looks like a punt at 0.006 ???
low cap stock with potential??
was looking good last year.. with lots of happening,, i believe it should get going soon


 
RADIO
post Posted: Aug 12 2008, 12:56 PM
  Quote Post


Posts: 3,268
Thanks: 9


user posted image
Recent ShareScene.com Radio Broadcast (06/08/2008 11:30:00):
STI - Shareholder Update 2nd Quarter 2008 - Dr Calvin London, MD

N.B. ShareScene.com Radio can normally be accessed by the 'RADIO' link, top of every page.
-------------------------------------------------------------------------------------------------------------
ShareScene.com Radio delivers investor presentations from ASX listed companies. Keep up to date with the latest corporate dealings of the shares you follow. Hear news direct from the source. Listen to directors and investor relations mangers discuss their company, give investor updates and brief on current results. ShareScene.com Radio keeps you informed about company announcements and events, and provides you daily market wraps and industry discussions.
-------------------------------------------------------------------------------------------------------------



 
 


42 Pages (Click to Jump) V  < 1 2 3 4 5 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING